Back
Dr Reddy's Laboratories 10K Form
Buy
67
RDY
Dr Reddy's Laboratories
Last Price:
$15.38
Seasonality Move:
-0.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RDY News And Ratings
See the #1 stock for the next 7 days that we like better than RDY
RDY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.4B |
|---|---|
| Cash Flow: | $16.7M |
| Price / Cash Flow: | 126.93 |
| Annual Sales: | $4.38 |
| Price / Book: | 3.51 |
Profitability
| EPS (TTM): | 0.46660 |
|---|---|
| Net Income (TTM): | $651.8M |
| Gross Margin: | $2B |
| Return on Equity: | 19.35% |
| Return on Assets: | 14.21% |
Dr Reddy's Laboratories Earnings Forecast
Key Dr Reddy's Laboratories Financial Ratios
-
The Gross Profit Margin over the past 24 years for RDY is 58.61%.
-
The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
-
The Research & Development expenses have been 8.19% of Revenue.
-
The Interest Expense is 3.07% of Operating Income.
-
The Net Earning history of RDY is 19.95% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 14 years.
Dr Reddy's Laboratories Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RDY |
| CUSIP: | 256135 |
| Website: | drreddys.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 1.92 |
| Quick Ratio: | 1.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.05 |
|---|---|
| Forward P/E Ratio: | 19.34 |
RDY Technical Analysis vs Fundamental Analysis
Buy
67
Dr Reddy's Laboratories (RDY)
is a Buy
Is Dr Reddy's Laboratories a Buy or a Sell?
-
Dr Reddy's Laboratories stock is rated a BuyThe current Dr Reddy's Laboratories [RDY] share price is $15.37. The Score for RDY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.